![Midas Letter artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/2c/4e/cf/2c4ecf27-ab36-2e1d-a35a-bbbb4c5e778e/mza_7613771131593152956.jpg/100x100bb.jpg)
Braxia Scientific (BRAX) Developing Ketamine Treatments of the Future
Midas Letter
English - September 08, 2021 13:00 - 11.4 MB - ★★★★ - 7 ratingsInvesting Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: What is Kevin O’Leary’s Latest Crypto Investment? | WonderFi (WNDR)
Next Episode: Don’t Miss These Cannabis Stocks
Braxia Scientific Corp (CNSX:BRAX, OTCMKTS:BRAXF) is a medical research psychedelics company that owns a global network of clinics providing innovative ketamine treatments for persons with depression and related disorders. The company successfully expanded its network of multidisciplinary clinics to four earlier this year, with […]